These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 14978701)

  • 1. Successful treatment of a patient with HIV-associated multicentric Castleman disease (MCD) with thalidomide.
    Jung CP; Emmerich B; Goebel FD; Bogner JR
    Am J Hematol; 2004 Mar; 75(3):176-7. PubMed ID: 14978701
    [No Abstract]   [Full Text] [Related]  

  • 2. Complete regression of HIV-associated multicentric Castleman disease treated with rituximab and thalidomide.
    Stary G; Kohrgruber N; Herneth AM; Gaiger A; Stingl G; Rieger A
    AIDS; 2008 Jun; 22(10):1232-4. PubMed ID: 18525273
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma HHV-8 viral load in HHV-8-related lymphoproliferative disorders associated with HIV infection.
    Simonelli C; Tedeschi R; Gloghini A; Talamini R; Bortolin MT; Berretta M; Spina M; Morassut S; Vaccher E; De Paoli P; Carbone A; Tirelli U
    J Med Virol; 2009 May; 81(5):888-96. PubMed ID: 19319955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alleviation of systemic manifestations of multicentric Castleman's disease by thalidomide.
    Lee FC; Merchant SH
    Am J Hematol; 2003 May; 73(1):48-53. PubMed ID: 12701121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Near-total resolution of multicentric Castleman disease by prolonged treatment with thalidomide.
    Starkey CR; Joste NE; Lee FC
    Am J Hematol; 2006 Apr; 81(4):303-4. PubMed ID: 16550518
    [No Abstract]   [Full Text] [Related]  

  • 6. Castleman's Disease. A Review.
    Roca B
    AIDS Rev; 2009; 11(1):3-7. PubMed ID: 19290029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of rituximab as a salvage therapy for HIV-associated multicentric Castleman disease.
    Casquero A; Barroso A; Fernández Guerrero ML; Górgolas M
    Ann Hematol; 2006 Mar; 85(3):185-7. PubMed ID: 16341862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicentric Castleman's disease in a patient with HIV.
    Fowler A; Collins L; de Ruiter A; Whittaker S; Kulasegaram R; Bradbeer C
    Int J STD AIDS; 2006 Jan; 17(1):63-4. PubMed ID: 16409683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Castleman disease in an HIV-infected patient with Kaposi sarcoma.
    Saif MW
    AIDS Read; 2001 Nov; 11(11):572-6. PubMed ID: 11789020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Castleman's disease and HIV infection in Australia.
    Loi S; Goldstein D; Clezy K; Milliken ST; Hoy J; Chipman M
    HIV Med; 2004 May; 5(3):157-62. PubMed ID: 15139981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thalidomide treatment for refractory HIV-associated colitis: a case series.
    Johnson L; Jarvis JN; Wilkins EG; Hay PE
    Clin Infect Dis; 2008 Jul; 47(1):133-6. PubMed ID: 18494607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV-8)-infected B cells in HIV+ multicentric Castleman disease (MCD).
    Chadburn A; Hyjek EM; Tam W; Liu Y; Rengifo T; Cesarman E; Knowles DM
    Histopathology; 2008 Nov; 53(5):513-24. PubMed ID: 18983461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of rituximab in human immunodeficiency virus-associated multicentric Castleman disease.
    Neuville S; Agbalika F; Rabian C; Brière J; Molina JM
    Am J Hematol; 2005 Aug; 79(4):337-9. PubMed ID: 16044438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicentric Castleman's disease in HIV infection.
    Collins LS; Fowler A; Tong CY; de Ruiter A
    Int J STD AIDS; 2006 Jan; 17(1):19-24; quiz 25. PubMed ID: 16409673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph nodes involved by multicentric Castleman disease among HIV-positive individuals are often involved by Kaposi sarcoma.
    Naresh KN; Rice AJ; Bower M
    Am J Surg Pathol; 2008 Jul; 32(7):1006-12. PubMed ID: 18469709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab and thalidomide combination therapy for Castleman disease.
    Ramasamy K; Gandhi S; Tenant-Flowers M; Ceesay M; Corderoy S; Marcus R; Schey S
    Br J Haematol; 2012 Aug; 158(3):421-3. PubMed ID: 22583139
    [No Abstract]   [Full Text] [Related]  

  • 17. What Is the best treatment for HIV-associated multicentric Castleman disease?
    Bower M; Dalla Pria A
    Clin Adv Hematol Oncol; 2012 Mar; 10(3):207-9. PubMed ID: 22402432
    [No Abstract]   [Full Text] [Related]  

  • 18. Thalidomide therapy for the treatment of hypertrophic herpes simplex virus-related genitalis in HIV-infected individuals.
    Holmes A; McMenamin M; Mulcahy F; Bergin C
    Clin Infect Dis; 2007 Jun; 44(11):e96-9. PubMed ID: 17479932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS 117 CastlemaB Trial.
    Gérard L; Bérezné A; Galicier L; Meignin V; Obadia M; De Castro N; Jacomet C; Verdon R; Madelaine-Chambrin I; Boulanger E; Chevret S; Agbalika F; Oksenhendler E
    J Clin Oncol; 2007 Aug; 25(22):3350-6. PubMed ID: 17664482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective analysis of thalidomide therapy in non-HIV-related Kaposi's sarcoma.
    Ben M'barek L; Fardet L; Mebazaa A; Thervet E; Biet I; Kérob D; Morel P; Lebbe C
    Dermatology; 2007; 215(3):202-5. PubMed ID: 17823515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.